SCHEMBL1302641

SCHEMBL1302641

CN(C)CCCN1c2ccccc2S(=O)(=O)c2ccccc21

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 9/20 0.58
CYP2D6 P10635 8/20 0.58
MAPT P10636 7/20 0.58
HTR1A P08908 7/20 0.58
DRD2 P14416 7/20 0.58
CYP1A2 P05177 7/20 0.58
HRH1 P35367 6/20 0.58
SLC6A4 P31645 6/20 0.58
TP53 P04637 6/20 0.58
HTR2A P28223 5/20 0.58
HTR6 P50406 5/20 0.58
CHRM2 P08172 5/20 0.58
CHRM1 P11229 5/20 0.58
DRD1 P21728 5/20 0.58
SLC6A2 P23975 5/20 0.58
ADRA1A P35348 5/20 0.58
OPRM1 P35372 5/20 0.58
DRD3 P35462 5/20 0.58
KCNH2 Q12809 5/20 0.58
SLC22A1 O15245 4/20 0.58

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5153952 0.88 MAPT (0.59) LMNACYP2D6MAPTHTR1ADRD2
SCHEMBL9768806 0.85 CYP2D6 (0.56) LMNACYP2D6MAPTHTR1ADRD2
SCHEMBL14281166 0.84 RXFP1 (0.61) LMNAMAPTHTR1ATP53HTR2A
SCHEMBL10349326 0.79 CES1 (0.53) LMNAMAPTTP53ALDH1A1CNR1
SCHEMBL4194693 0.79 CES1 (0.53) LMNAMAPTTP53ALDH1A1CNR1
SCHEMBL32667803 0.79 CES1 (0.53) LMNAMAPTTP53ALDH1A1CNR1
SCHEMBL11182750 0.75 RXFP1 (0.51) LMNAMAPTHTR1ATP53HTR2A
Depramine SCHEMBL29489714 0.75 HTR1A (0.73) LMNACYP2D6MAPTHTR1ADRD2
SCHEMBL12265301 0.75 CYP2D6 (0.66) LMNACYP2D6MAPTHTR1ADRD2
Depramine SCHEMBL2108027 0.75 HTR1A (0.73) LMNACYP2D6MAPTHTR1ADRD2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 204 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240226084-A9 HIGH PENETRATION PRODRUG COMPOSITIONS AND PHARMACEUTICAL COMPOSITION THEREOF FOR TREATMENT OF PULMONARY CONDITIONS TECHFIELDS PHARMA CO., LTD. (CN) 2024-07-11 US claimed
US-20240131017-A1 HIGH PENETRATION PRODRUG COMPOSITIONS AND PHARMACEUTICAL COMPOSITION THEREOF FOR TREATMENT OF PULMONARY CONDITIONS TECHFIELDS PHARMA CO., LTD. (CN) 2024-04-25 US claimed
US-20240115562-A1 HIGH PENETRATION PRODRUG COMPOSITIONS AND PHARMACEUTICAL COMPOSITION THEREOF FOR TREATMENT OF PULMONARY CONDITIONS TECHFIELDS PHARMA CO., LTD. (CN) 2024-04-11 US claimed
CN-115703749-A Dioxopropizine hydrochloride nitrogen oxide and preparation method thereof 河南优凯制药有限公司 2023-02-17 CN claimed
CN-111943910-B Dioxopropazine hydrochloride and preparation method thereof 上海金不换兰考制药有限公司 2022-09-09 CN claimed
CN-114609310-A Sample pretreatment method and detection method for detecting sedative residue in milk by chromatography-mass spectrometry 中国农业科学院农业质量标准与检测技术研究所 2022-06-10 CN claimed
CN-111943910-A Dioxopropazine hydrochloride and preparation method thereof 河南优凯制药有限公司 2020-11-17 CN claimed
CN-111419960-A Compound antitussive pharmaceutical composition and preparation method thereof 辽宁修和药业有限公司 2020-07-17 CN claimed
CN-109833403-A A kind of formula of cold drug 徐彩玲 2019-06-04 CN claimed
CN-106732475-B A kind of HPLC chiral stationary phase and its preparation method and application 青岛大学 2019-05-28 CN claimed
CN-1478477-A Pectoral 王鹏程 2004-03-03 CN claimed
CN-1094060-C Medicinal composition for treating cough and preparation process thereof WANG SHOUDONG (CN) 2002-11-13 CN claimed
CN-1379047-A Match of organic medicine and beta-cyclodextrin derivative and its preparing process LIU YUNQING (CN) 2002-11-13 CN claimed
CN-1358534-A Compound medicine for treating bronchial asthma and preparation process WANG ZHIQIANG (CN) 2002-07-17 CN claimed
CN-1058176-C Compounded Chuanlin Dingchuan capsule for asthma LIU GUANGQING (CN) 2000-11-08 CN claimed
CN-1267537-A Medicinal composition for asthma and trachitis and its preparation WANG XINSHAN (CN) 2000-09-27 CN claimed
CN-1256942-A Medicinal composition for treating cough and preparation process thereof WANG SHOUDONG (CN) 2000-06-21 CN claimed
CN-1239670-A Compound capsule for treating asthma TIAN KAIGUI (CN) 1999-12-29 CN claimed
CN-1232671-A Compound kechuankang capsule for cough and asthma LIU ZEHUA (CN) 1999-10-27 CN claimed
CN-1179976-A Huatan Pingchuanjing medicine for curing respiratory system diseases YIN QINGCHENG (CN) 1998-04-29 CN claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240226084-A9 HIGH PENETRATION PRODRUG COMPOSITIONS AND PHARMACEUTICAL COMPOSITION THEREOF FOR TREATMENT OF PULMONARY CONDITIONS HRH4, HCAR2, PAH LMNA 1999/4885CYP2D6 153/4885MAPT 2541/4885
US-20240115562-A1 HIGH PENETRATION PRODRUG COMPOSITIONS AND PHARMACEUTICAL COMPOSITION THEREOF FOR TREATMENT OF PULMONARY CONDITIONS HRH4, HCAR2, PAH LMNA 1999/4885CYP2D6 153/4885MAPT 2541/4885
US-20240131017-A1 HIGH PENETRATION PRODRUG COMPOSITIONS AND PHARMACEUTICAL COMPOSITION THEREOF FOR TREATMENT OF PULMONARY CONDITIONS HRH4, HCAR2, PAH LMNA 1999/4885CYP2D6 153/4885MAPT 2541/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.